UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The ...
Mr. Finney brings 35 years of leadership, operations and corporate development experience SOUTH SAN FRANCISCO, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the “Company” or ...
GSK (GSK) stock in focus as its experimental drug depemokimab undergoes EU review for asthma and nasal polyps. Read more here ...
FTSE rebounds to edge higher amid strong consumer stocks - The FTSE 100 finished 1.36 points higher to end the day at ...
Pharmacies play a key role in improving drug development and patient care, offering insights, clinical trial support and ...
In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target ...
Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...
At-home DNA testing is no longer in high demand — and critics have raised concerns about unreliable tests and privacy.
“We are pleased to welcome Reena to Applied and are confident that her wealth of experience as a leader across quality functions will support our mission of meeting the unmet needs of patients with ...
We recently published a list of 12 Undervalued Defensive Stocks for 2025. In this article, we are going to take a look at ...
In his first public comments since one of his executives was shot to death, UnitedHealth Group CEO Andrew Witty said the ...